LONGMONT, Colo. — ANDE Corporation, the global leader in Rapid DNA, today announced the availability of its Rapid DNA Booking Management product suite, which is available for immediate delivery. Effective February 1, 2021, ANDE received approval from the FBI for its technology to be deployed in booking stations to support processing of DNA samples from […]

BEVERLY, Mass. — SeqWell, a leader in genomic technologies, announced the release of its plexWell Single Cell Rapid Kit, simplifying and accelerating the preparation of NGS libraries for single-cell RNA sequencing. plexWell Single Cell Rapid is the first in a series of products in the single-cell analysis area and offers a comprehensive library prep solution employing […]

With only two PCR reactions, the Shiga toxins (stx1, stx2), the adherence factor intimin (eae) and the eight most important STEC serogroups can be detected and individually identified Potsdam – We are pleased to announce that our foodproof STEC Screening LyoKit and STEC Identification LyoKit in combination with our extraction kit, StarPrep Three, have now […]

REDWOOD CITY, Calif. — GenapSys Inc. (GenapSys), the company behind the world’s first highly accurate, affordable, and accessible gene sequencer, today announced it has named Jason Myers as its Chief Executive Officer, effective February 15, 2021. He will also join the GenapSys Board of Directors. Myers will succeed Dr. Hesaam Esfandyarpour, founder and CEO of […]

Study will measure the impact of comprehensive genomic profiling on access to, and uptake of, personalized medicines and on clinical outcomes for patients SAN DIEGO — Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Society of Medical Oncology (BSMO) which is running a new national pilot to evaluate the use of comprehensive genomic […]

BALLETT Study will measure the impact of comprehensive genomic profiling on access to, and uptake of, personalized medicines and on clinical outcomes for patients PierianDx, the global leader in clinical genomics knowledge, today announced a partnership with the Belgian Society of Medical Oncology (BSMO) to study the impact of comprehensive genomic profiling (CGP) on clinical […]

A pioneer in the development of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS) systems Swift Biosciences announces the addition of Bruce Zhang, Director of Sales and Marketing, APAC to its global commercial team.  Bruce comes to Swift with ten years of rich experience and has led efforts in increasing product adoption in his previous companies […]

— Team Promotions and Appointments Reflect Corporate Growth — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced several senior management promotions and team expansion. “Twist is growing at a significant rate, meeting and exceeding […]

John C. Spinosa, M.D., Ph.D., has joined the executive management team as our Chief Medical Officer. “We are fortunate to have attracted Dr. Spinosa to join us,” stated Jay Goth, CEO. “John’s background and experience with companies large and small will be critical to our future success helping genomic sequencing companies revolutionize the healthcare, agriculture […]

BOSTON, MA and PARIS, FRANCE – Stilla Technologies is pleased to announce the appointment of Mr. Philippe Mourere as its new Chief Executive Officer. Former CEO and FounderDr. Rémi Danglahas beenappointed Chief Technology Officer and remains a member of the Board of Directors. Stilla technologies was founded in 2013 and is a global leader in […]